ASH1L and cancer: Collectively, our comprehensive single-cell transcriptomic analyses and functional validation suggest that ASH1L in invading cancer cells reshapes metastatic bone niches by promoting monocyte differentiation into lipid-associated and angiogenic TAMs and reprogramming them toward pro-tumoral and anti-inflammatory states.